22 insiders have filed at APLS since 2023Q3: names, roles, reported stakes, and each person's buying and selling record from SEC Form 3/4/5 filings.
| name | role | reported stake | % of company | buys (3y) | sells (3y) |
|---|---|---|---|---|---|
| Francois Cedric | Chief Executive Officer | 1.81M | 1.374% | 24 sells $35.8M | |
| Deschatelets Pascal | Chief Scientific Officer | 1.18M | 0.896% | 24 sells $15.2M | |
| Machiels Alec | Director | 796.9k | 0.606% | 5 sells $314k | |
| Sullivan Timothy Eugene | Chief Financial Officer | 212.4k | 0.162% | 22 sells $4.6M | |
| Watson David O. | General Counsel | 204.7k | 0.156% | 24 sells $4.0M | |
| Dunlop A. Sinclair | Director | 161.6k | 0.123% | 11 sells $9.1M | |
| Boucher Kelley | Chief People Officer | 127.8k | 0.097% | ||
| Nicholson Nur | Chief Technical Officer | 116.3k | 0.089% | 14 sells $2.4M | |
| Delong Mark Jeffrey | Chief Business & Strat Officer | 114.6k | 0.087% | 15 sells $1.1M | |
| Meltzer Leslie | Chief Research And Development | 107.0k | 0.081% | ||
| Baumal Caroline | Chief Medical Officer | 86.5k | 0.066% | 6 sells $491k | |
| Townsend Adam J. | Chief Commercial Officer | 84.0k | 0.064% | 10 sells $7.5M | |
| Lewis Karen | Chief People Officer | 70.3k | 0.053% | 10 sells $938k | |
| Scheibler Lukas | Chief Research Officer | 68.3k | 0.052% | 2 sells $676k | |
| Chopas James George | VP/Chief Accounting Officer | 66.0k | 0.05% | 16 sells $375k | |
| Eisele Jeffrey | Chief Development Officer | 55.3k | 0.042% | 12 sells $1.1M | |
| Fonteyne Paul R. | Director | 30.7k | 0.023% | ||
| O'Brien Stephanie Monaghan | Director | 25.7k | 0.02% | ||
| Chan Gerald | Director | 25.7k | 0.02% | ||
| Wheeler Craig A | Director | 24.4k | 0.019% | ||
| Walbert Keli | Director | 17.1k | 0.013% | ||
| Dolsten Mikael | Director | 14.3k | 0.011% |
Full register at boothcheck.com/insiders/APLS. Stakes are the newest reported Form 3/4/5 balances (they update only when insiders file). Sales counted include pre-scheduled plan sales, labeled. A filed record, not a forecast. Nothing here is investment advice.